Welcome to GENESIS Hangzhou!

page_banner

product

Newly Arrival Test Antigen - KaiBiLi COVID-19 Antigen – Genesis


Product Detail

Related Video

Feedback (2)

Our team through qualified training. Skilled professional knowledge, powerful sense of support, to satisfy the support desires of consumers for Molecular Infectious Disease, Saliva Specimen, Diagnostic Molecular, The mission of our firm should be to provide the best high quality goods with finest price tag. We've been on the lookout forward to doing organization with you!
Newly Arrival Test Antigen - KaiBiLi COVID-19 Antigen – Genesis Detail:

Introduction

COVID-19 is an acute respiratory infectious disease. People are generally susceptible. Currently, the patients infected by the novel coronavirus are the main source of infection; asymptomatic infected people can also be an infectious source. Based on the current epidemiological investigation, the incubation period is 1 to 14 days, mostly 3 to 7 days. The main symptoms including manifestations include fever, fatigue and dry cough, nasal congestion, runny nose, sore throat, myalgia and diarrhea are found in a few cases.

The KaiBiLiTM COVID-19 Antigen Rapid Test Device is an in vitro diagnostic test based on the principle of immunochromatography for the qualitative detection of 2019 Novel Coronavirus nucleocapsid protein antigens in nasal swab or nasopharyngeal swab. The detection is based on the antibodies which were developed specifically recognizing and reacting with the nucleoprotein of 2019 Novel Coronavirus. It is intended to aid in the rapid diagnosis of SARS-CoV-2 infection.

This assay is intended for rapid screening in laboratory. This test should be conducted by trained technician, wearing appropriate personal protective equipment (PPE). 

Detection

The qualitative detection of 2019 Novel Coronavirus nucleocapsid protein antigens in nasal swab or nasopharyngeal swab.

Specimen

Nasal or nasopharyngeal 

Limit of Detection (LoD)

2019 Novel Coronavirus: 140 TCID50/mL

ACCURACY (Nasal swab)

Positive Percent Agreement: 96.6%

Negative Percent Agreement:100%

Overall Percent Agreement: 98.9%

ACCURACY (Nasopharyngeal swab)

Positive Percent Agreement: 97.0%

Negative Percent Agreement:98.3%

Overall Percent Agreement: 97.7%

Time to Results

Read results at 15minutes and no more than 30 minutes. 

Kit storage conditions

2~30°C. 

Contents

Description

Qty

COVID-19 antigen test devices

20

Sterilized swabs

20

Extraction tubes (with 0.5mL extraction buffer)

20

Nozzles with filter

20

Tube Stand

1

Package Insert

1

Ordering Information

Product

Cat.No.

Contents

KaiBiLiTM COVID-19 Antigen 

P211139

20 Tests


Product detail pictures:

Newly Arrival  Test Antigen - KaiBiLi COVID-19 Antigen – Genesis detail pictures

Newly Arrival  Test Antigen - KaiBiLi COVID-19 Antigen – Genesis detail pictures

Newly Arrival  Test Antigen - KaiBiLi COVID-19 Antigen – Genesis detail pictures


Related Product Guide:

Bear "Customer first, Quality first" in mind, we work closely with our customers and provide them with efficient and professional services for Newly Arrival Test Antigen - KaiBiLi COVID-19 Antigen – Genesis , The product will supply to all over the world, such as: Montreal, Bhutan, Uganda, Our company always provides good quality and reasonable price for our customers. In our efforts, we already have many shops in Guangzhou and our products have won praise from customers worldwide. Our mission has always been simple: To delight our customers with best quality hair products and deliver on time. Welcome new and old customers to contact us for the future long term business relationships.
This enterprise in the industry is strong and competitive, advancing with the times and develop sustainable, we are very pleased to have a opportunity to cooperate!
5 Stars By Sophia from Istanbul - 2017.11.01 17:04
The company account manager has a wealth of industry knowledge and experience, he could provide appropriate program according our needs and speak English fluently.
5 Stars By Quintina from Maldives - 2017.05.02 18:28
Write your message here and send it to us